JP Morgan Chase
IQMD

JP Morgan Chase’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

JP Morgan Chase’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100,000
Closed -$1M – 7044
2022
Q2 		$1M Sell
100,000
-98,900
-50% -$989K ﹤0.01% 4076
2022
Q1 		$1.99M Buy
+198,900
New +$1.98M ﹤0.01% 3755

Other funds holding IQMD

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

JP Morgan Chase's IQMD Position: Q3 2022 in Review

JP Morgan Chase sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q3 2022, closing a stake of 100,000 shares — an estimated $1M sold.

JP Morgan Chase first reported a position in IQMD in Q1 2022 and held it in 2 quarters. The position peaked at $1.99M in Q1 2022. 58 funds tracked by Wall St. Rank hold IQMD as of Q3 2022.

  • JP Morgan Chase reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Chase sold 100,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $1M.
  • JP Morgan Chase first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 2 quarters.
  • JP Morgan Chase's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $1.99M in Q1 2022.
  • 58 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.